Cargando…
Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
OBJECTIVES: Gonadotropin-releasing hormone (GnRH) stimulates immune responses; therefore, antagonizing GnRH with cetrorelix may have anti-inflammatory effects. The aim of this study was to assess short-term cetrorelix therapy in rheumatoid arthritis (RA) patients. METHOD: In this proof-of-concept, r...
Autores principales: | Kåss, AS, Førre, ØT, Fagerland, MW, Gulseth, HC, Torjesen, PA, Hollan, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913106/ https://www.ncbi.nlm.nih.gov/pubmed/24182325 http://dx.doi.org/10.3109/03009742.2013.825007 |
Ejemplares similares
-
Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial
por: Kåss, Anita, et al.
Publicado: (2015) -
Cetrorelix in reproductive medicine
por: Findeklee, Sebastian, et al.
Publicado: (2022) -
Efficacy and Safety of gonadotropin-releasing hormone (GnRH) Agonists Triptorelin Acetate and Cetrorelix Acetate in Assisted Reproduction
por: Jiang, Jingjing, et al.
Publicado: (2018) -
Effect of Cetrorelix administration on ovarian stimulation in aged
mice
por: Kanda, Akifumi, et al.
Publicado: (2020) -
IANCON 2015: Agra
por: Khadilkar, Satish V
Publicado: (2015)